Bromopyruvic acid

The primary application of bromopyruvic acid lies in its potential as an anticancer drug. Its ability to inhibit critical metabolic pathways makes it a candidate for targeted cancer therapies. Research has indicated that it may enhance the effectiveness of existing treatments by disrupting energy supply in rapidly dividing cancer cells. Furthermore, its properties as an alkylating agent suggest potential uses in other therapeutic areas where modification of protein function is desirable.

Bromopyruvic acid exhibits significant biological activity, particularly in cancer research. It has been identified as a potential anticancer agent due to its ability to disrupt energy metabolism in cancer cells. The compound inhibits aerobic glycolysis and oxidative phosphorylation, leading to cell death in tumor cells while sparing normal cells. Its mechanism involves targeting monocarboxylate transporters that are overexpressed in many cancer types, facilitating its uptake into malignant cells. Additionally, bromopyruvic acid's action on cellular metabolism suggests that it may also act as a radiosensitizer, enhancing the effects of radiation therapy.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.